VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
7294
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1021
Interactions with Platform & by Email
PARTICIPANTS
219
Unique # Participated
VALIDATIONS
99
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
297
PAGES
362
EDITION
17
PRICE
USD $5600
Focus On Polymer-Free, One of the Largest Segments in the Drug-Eluting Stents Market.
Will this Market be a Huge Opportunity by 2025?
COVID-19 IMPACT SURVEY
GLOBAL EXECUTIVE SURVEY
Impact of Pandemic & Economic Slowdown
Monitor Market Dynamics!
Early March 2020, we reached out to senior enterprise executives who are driving strategy, business development, marketing, sales, product management, technology and operations at competitive firms worldwide. Our ongoing survey is focused on how this will this affect their business ecosystems. We invite you to participate in our survey and add to collective perspectives. Market movements are tracked for 2020, 2021 and broadly for the period of 2022 through 2025. Critical changes are monitored dynamically for the rest of this year. Updated analytics will reflect new and evolving market realities. Our first update scheduled for May 2020 and another in the Fall. Clients receive complimentary updates during 2020. If your company is a recent client for this project, we may have already reached out to your colleagues to participate in our program. If you're an active player in the space but hasn't yet subscribed to our project, we invite you to participate and share your perspectives. Please sign-up here.
Amid the COVID-19 crisis, the global market for Drug-Eluting Stents estimated at US$5.7 Billion in the year 2020, is projected to reach a revised size of US$7.5 Billion by 2027, growing at aCAGR of 4% over the period 2020-2027. Polymer-Free, one of the segments analyzed in the report, is projected to record 4.3% CAGR and reach US$5.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polymer-based segment is readjusted to a revised 3.4% CAGR for the next 7-year period.
The Drug-Eluting Stents market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 7.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.2% and 3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.We bring years of research experience to this 17th edition of our report. The 362-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abbott Laboratories; AlviMedica; Arterius Limited; Biotronik SE; Boston Scientific Corporation; Cook Medical; Medtronic plc ; STENTYS SA; Terumo Corporation
» Coating (Polymer-Free, Polymer-based) » Application (Coronary Artery Disease, Peripheral Artery Disease) » End-Use (Cardiology Centers, Ambulatory Surgical Centers, Hospitals)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Coronary Stents Market - A Prelude |
| Recent Market Activity |
| Competitive Scenario |
| J&J Exit from DES Market Improves Prospects for Competitors |
| Evolution of the Drug-Eluting Stent |
| Evolution of Drug-Eluting Stents (DES) Over the Years |
| Comparative Analysis of Drug-Eluting Stents in Terms of Physical Parameters |
| Bioabsorbable Stents |
| New Stents with Biodegradable Polymers |
| Completely Bioresorbable Scaffolds: Potential Game-Changer |
| Noteworthy Clinical Studies and Innovations |
| Study Proves Efficacy of Very Thin Strut DES On Par with Durable Polymer Stents |
| Drug-Eluting Stents and Drug-Coated Balloons for Non-Coronary Indications |
| DES for Large Sized Arteries |
| Addressing the Unmet Challenges in Patients with Diabetes |
| Biosensors Commercializes BMX-J DES System |
| SLENDER DES Set to Downsize the Future of Interventional Cardiology |
| Other Novel DES Launches |
| Researchers at University of Strathclyde Evaluate VAN 10-4 Small Molecule |
| DES Safe for Vein Grafts Procedures |
| Global Competitor Market Shares |
| Drug-Eluting Stents Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Abbott Laboratories (US) |
| AlviMedica (Turkey) |
| Arterius Limited (UK) |
| B. Braun Melsungen AG (Germany) |
| Biosensors International Group, Ltd. (Singapore) |
| Shandong JW Medical Systems LTD. (China) |
| Biotronik SE & Co. KG (Germany) |
| Boston Scientific Corporation (US) |
| Cook Medical Inc. (US) |
| Elixir Medical Corp. (US) |
| KYOTO MEDICAL PLANNING Co., Ltd. (Japan) |
| Lepu Medical Technology (Beijing) Co., Ltd. (China) |
| Medtronic plc (Republic of Ireland) |
| Micell Technologies, Inc. (US) |
| Opto Circuits (India) Ltd (India) |
| Eurocor GmbH (Germany) |
| OrbusNeich Medical Company Limited (Hong Kong) |
| QualiMed (Germany) |
| Shanghai MicroPort Medical (Group) Co., Ltd. (China) |
| Sino Medical Sciences Technology Inc. (China) |
| STENTYS SA (France) |
| Terumo Corporation (Japan) |
| 3. MARKET TRENDS & DRIVERS |
| Key Market Drivers & Restraints |
| Aging - A Key Market Driver |
| Global Aging Population Demographic Statistics: Key Opportunity Indicator |
| High Diabetes Incidence Worldwide Drives Demand for Cardiac Surgery and Stents |
| 4. GLOBAL MARKET PERSPECTIVE |
| Drug-Eluting Stents Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Drug-Eluting Stents Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Drug-Eluting Stents Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Polymer-Free (Coating) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Polymer-Free (Coating) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Polymer-Free (Coating) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Polymer-based (Coating) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Polymer-based (Coating) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Polymer-based (Coating) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Coronary Artery Disease (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025 |
| Coronary Artery Disease (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017 |
| Coronary Artery Disease (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Peripheral Artery Disease (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025 |
| Peripheral Artery Disease (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Peripheral Artery Disease (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 |
| Cardiology Centers (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025 |
| Cardiology Centers (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2009-2017 |
| Cardiology Centers (End-Use) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Ambulatory Surgical Centers (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025 |
| Ambulatory Surgical Centers (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017 |
| Ambulatory Surgical Centers (End-Use) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 |
| Hospitals (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025 |
| Hospitals (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Hospitals (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Drug-Eluting Stents Market Share (in %) by Company: 2018 & 2025 |
| United States Drug-Eluting Stents Market Estimates and Projections in US$ Million by Coating: 2018 to 2025 |
| Drug-Eluting Stents Market in the United States by Coating: A Historic Review in US$ Million for 2009-2017 |
| United States Drug-Eluting Stents Market Share Breakdown by Coating: 2009 VS 2019 VS 2025 |
| United States Drug-Eluting Stents Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Drug-Eluting Stents Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017 |
| Drug-Eluting Stents Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 |
| United States Drug-Eluting Stents Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025 |
| Drug-Eluting Stents Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017 |
| Drug-Eluting Stents Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025 |
| Canada |
| Canadian Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2018 to 2025 |
| Canadian Drug-Eluting Stents Historic Market Review by Coating in US$ Million: 2009-2017 |
| Drug-Eluting Stents Market in Canada: Percentage Share Breakdown of Sales by Coating for 2009, 2019, and 2025 |
| Canadian Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Drug-Eluting Stents Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Canadian Drug-Eluting Stents Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Canadian Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025 |
| Drug-Eluting Stents Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017 |
| Canadian Drug-Eluting Stents Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| Japan |
| Japanese Market for Drug-Eluting Stents: Annual Sales Estimates and Projections in US$ Million by Coating for the Period 2018-2025 |
| Drug-Eluting Stents Market in Japan: Historic Sales Analysis in US$ Million by Coating for the Period 2009-2017 |
| Japanese Drug-Eluting Stents Market Share Analysis by Coating: 2009 VS 2019 VS 2025 |
| Japanese Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by Application: 2018 to 2025 |
| Japanese Drug-Eluting Stents Market in US$ Million by Application: 2009-2017 |
| Drug-Eluting Stents Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 |
| Japanese Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by End-Use: 2018 to 2025 |
| Japanese Drug-Eluting Stents Market in US$ Million by End-Use: 2009-2017 |
| Drug-Eluting Stents Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025 |
| China |
| Chinese Drug-Eluting Stents Market Growth Prospects in US$ Million by Coating for the Period 2018-2025 |
| Drug-Eluting Stents Historic Market Analysis in China in US$ Million by Coating: 2009-2017 |
| Chinese Drug-Eluting Stents Market by Coating: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Demand for Drug-Eluting Stents in US$ Million by Application: 2018 to 2025 |
| Drug-Eluting Stents Market Review in China in US$ Million by Application: 2009-2017 |
| Chinese Drug-Eluting Stents Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Chinese Demand for Drug-Eluting Stents in US$ Million by End-Use: 2018 to 2025 |
| Drug-Eluting Stents Market Review in China in US$ Million by End-Use: 2009-2017 |
| Chinese Drug-Eluting Stents Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| Europe |
| Market Facts & Figures |
| European Drug-Eluting Stents Market: Competitor Market Share Scenario (in %) for 2018 & 2025 |
| European Drug-Eluting Stents Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Drug-Eluting Stents Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Drug-Eluting Stents Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2018-2025 |
| Drug-Eluting Stents Market in Europe in US$ Million by Coating: A Historic Review for the Period 2009-2017 |
| European Drug-Eluting Stents Market Share Breakdown by Coating: 2009 VS 2019 VS 2025 |
| European Drug-Eluting Stents Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Drug-Eluting Stents Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| European Drug-Eluting Stents Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| European Drug-Eluting Stents Addressable Market Opportunity in US$ Million by End-Use: 2018-2025 |
| Drug-Eluting Stents Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017 |
| European Drug-Eluting Stents Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| France |
| Drug-Eluting Stents Market in France by Coating: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Drug-Eluting Stents Historic Market Scenario in US$ Million by Coating: 2009-2017 |
| French Drug-Eluting Stents Market Share Analysis by Coating: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025 |
| French Drug-Eluting Stents Historic Market Review in US$ Million by Application: 2009-2017 |
| French Drug-Eluting Stents Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Drug-Eluting Stents Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025 |
| French Drug-Eluting Stents Historic Market Review in US$ Million by End-Use: 2009-2017 |
| French Drug-Eluting Stents Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| Germany |
| Drug-Eluting Stents Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Coating for the Period 2018-2025 |
| German Drug-Eluting Stents Historic Market Analysis in US$ Million by Coating: 2009-2017 |
| German Drug-Eluting Stents Market Share Breakdown by Coating: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| German Drug-Eluting Stents Market in Retrospect in US$ Million by Application: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025 |
| German Drug-Eluting Stents Market in Retrospect in US$ Million by End-Use: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025 |
| Italy |
| Italian Drug-Eluting Stents Market Growth Prospects in US$ Million by Coating for the Period 2018-2025 |
| Drug-Eluting Stents Historic Market Analysis in Italy in US$ Million by Coating: 2009-2017 |
| Italian Drug-Eluting Stents Market by Coating: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Demand for Drug-Eluting Stents in US$ Million by Application: 2018 to 2025 |
| Drug-Eluting Stents Market Review in Italy in US$ Million by Application: 2009-2017 |
| Italian Drug-Eluting Stents Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Italian Demand for Drug-Eluting Stents in US$ Million by End-Use: 2018 to 2025 |
| Drug-Eluting Stents Market Review in Italy in US$ Million by End-Use: 2009-2017 |
| Italian Drug-Eluting Stents Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| United Kingdom |
| United Kingdom Market for Drug-Eluting Stents: Annual Sales Estimates and Projections in US$ Million by Coating for the Period 2018-2025 |
| Drug-Eluting Stents Market in the United Kingdom: Historic Sales Analysis in US$ Million by Coating for the Period 2009-2017 |
| United Kingdom Drug-Eluting Stents Market Share Analysis by Coating: 2009 VS 2019 VS 2025 |
| United Kingdom Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by Application: 2018 to 2025 |
| United Kingdom Drug-Eluting Stents Market in US$ Million by Application: 2009-2017 |
| Drug-Eluting Stents Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 |
| United Kingdom Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by End-Use: 2018 to 2025 |
| United Kingdom Drug-Eluting Stents Market in US$ Million by End-Use: 2009-2017 |
| Drug-Eluting Stents Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025 |
| Spain |
| Spanish Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2018 to 2025 |
| Spanish Drug-Eluting Stents Historic Market Review by Coating in US$ Million: 2009-2017 |
| Drug-Eluting Stents Market in Spain: Percentage Share Breakdown of Sales by Coating for 2009, 2019, and 2025 |
| Spanish Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Drug-Eluting Stents Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Spanish Drug-Eluting Stents Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Spanish Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025 |
| Drug-Eluting Stents Market in Spain: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017 |
| Spanish Drug-Eluting Stents Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| Russia |
| Russian Drug-Eluting Stents Market Estimates and Projections in US$ Million by Coating: 2018 to 2025 |
| Drug-Eluting Stents Market in Russia by Coating: A Historic Review in US$ Million for 2009-2017 |
| Russian Drug-Eluting Stents Market Share Breakdown by Coating: 2009 VS 2019 VS 2025 |
| Russian Drug-Eluting Stents Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Drug-Eluting Stents Historic Demand Patterns in Russia by Application in US$ Million for 2009-2017 |
| Drug-Eluting Stents Market Share Breakdown in Russia by Application: 2009 VS 2019 VS 2025 |
| Russian Drug-Eluting Stents Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025 |
| Drug-Eluting Stents Historic Demand Patterns in Russia by End-Use in US$ Million for 2009-2017 |
| Drug-Eluting Stents Market Share Breakdown in Russia by End-Use: 2009 VS 2019 VS 2025 |
| Rest of Europe |
| Rest of Europe Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2018-2025 |
| Drug-Eluting Stents Market in Rest of Europe in US$ Million by Coating: A Historic Review for the Period 2009-2017 |
| Rest of Europe Drug-Eluting Stents Market Share Breakdown by Coating: 2009 VS 2019 VS 2025 |
| Rest of Europe Drug-Eluting Stents Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Drug-Eluting Stents Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Rest of Europe Drug-Eluting Stents Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Rest of Europe Drug-Eluting Stents Addressable Market Opportunity in US$ Million by End-Use: 2018-2025 |
| Drug-Eluting Stents Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017 |
| Rest of Europe Drug-Eluting Stents Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| Asia-Pacific |
| Asia-Pacific Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Drug-Eluting Stents Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017 |
| Asia-Pacific Drug-Eluting Stents Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in Asia-Pacific by Coating: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Drug-Eluting Stents Historic Market Scenario in US$ Million by Coating: 2009-2017 |
| Asia-Pacific Drug-Eluting Stents Market Share Analysis by Coating: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025 |
| Asia-Pacific Drug-Eluting Stents Historic Market Review in US$ Million by Application: 2009-2017 |
| Asia-Pacific Drug-Eluting Stents Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Drug-Eluting Stents Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025 |
| Asia-Pacific Drug-Eluting Stents Historic Market Review in US$ Million by End-Use: 2009-2017 |
| Asia-Pacific Drug-Eluting Stents Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| Australia |
| Drug-Eluting Stents Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Coating for the Period 2018-2025 |
| Australian Drug-Eluting Stents Historic Market Analysis in US$ Million by Coating: 2009-2017 |
| Australian Drug-Eluting Stents Market Share Breakdown by Coating: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Australian Drug-Eluting Stents Market in Retrospect in US$ Million by Application: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in Australia by Application: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025 |
| Australian Drug-Eluting Stents Market in Retrospect in US$ Million by End-Use: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in Australia by End-Use: 2009 VS 2019 VS 2025 |
| India |
| Indian Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2018 to 2025 |
| Indian Drug-Eluting Stents Historic Market Review by Coating in US$ Million: 2009-2017 |
| Drug-Eluting Stents Market in India: Percentage Share Breakdown of Sales by Coating for 2009, 2019, and 2025 |
| Indian Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Drug-Eluting Stents Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Indian Drug-Eluting Stents Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Indian Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025 |
| Drug-Eluting Stents Market in India: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017 |
| Indian Drug-Eluting Stents Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| South Korea |
| Drug-Eluting Stents Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Coating for the Period 2018-2025 |
| South Korean Drug-Eluting Stents Historic Market Analysis in US$ Million by Coating: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in South Korea by Coating: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025 |
| South Korean Drug-Eluting Stents Historic Market Analysis in US$ Million by Application: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in South Korea by Application: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2018-2025 |
| South Korean Drug-Eluting Stents Historic Market Analysis in US$ Million by End-Use: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in South Korea by End-Use: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific |
| Rest of Asia-Pacific Market for Drug-Eluting Stents: Annual Sales Estimates and Projections in US$ Million by Coating for the Period 2018-2025 |
| Drug-Eluting Stents Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Coating for the Period 2009-2017 |
| Rest of Asia-Pacific Drug-Eluting Stents Market Share Analysis by Coating: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by Application: 2018 to 2025 |
| Rest of Asia-Pacific Drug-Eluting Stents Market in US$ Million by Application: 2009-2017 |
| Drug-Eluting Stents Market Share Shift in Rest of Asia-Pacific by Application: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by End-Use: 2018 to 2025 |
| Rest of Asia-Pacific Drug-Eluting Stents Market in US$ Million by End-Use: 2009-2017 |
| Drug-Eluting Stents Market Share Shift in Rest of Asia-Pacific by End-Use: 2009 VS 2019 VS 2025 |
| Latin America |
| Latin American Drug-Eluting Stents Market Trends by Region/Country in US$ Million: 2018-2025 |
| Drug-Eluting Stents Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017 |
| Latin American Drug-Eluting Stents Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 |
| Latin American Drug-Eluting Stents Market Growth Prospects in US$ Million by Coating for the Period 2018-2025 |
| Drug-Eluting Stents Historic Market Analysis in Latin America in US$ Million by Coating: 2009-2017 |
| Latin American Drug-Eluting Stents Market by Coating: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Latin American Demand for Drug-Eluting Stents in US$ Million by Application: 2018 to 2025 |
| Drug-Eluting Stents Market Review in Latin America in US$ Million by Application: 2009-2017 |
| Latin American Drug-Eluting Stents Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Latin American Demand for Drug-Eluting Stents in US$ Million by End-Use: 2018 to 2025 |
| Drug-Eluting Stents Market Review in Latin America in US$ Million by End-Use: 2009-2017 |
| Latin American Drug-Eluting Stents Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| Argentina |
| Argentinean Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2018-2025 |
| Drug-Eluting Stents Market in Argentina in US$ Million by Coating: A Historic Review for the Period 2009-2017 |
| Argentinean Drug-Eluting Stents Market Share Breakdown by Coating: 2009 VS 2019 VS 2025 |
| Argentinean Drug-Eluting Stents Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Drug-Eluting Stents Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Argentinean Drug-Eluting Stents Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Argentinean Drug-Eluting Stents Addressable Market Opportunity in US$ Million by End-Use: 2018-2025 |
| Drug-Eluting Stents Market in Argentina: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017 |
| Argentinean Drug-Eluting Stents Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| Brazil |
| Drug-Eluting Stents Market in Brazil by Coating: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Brazilian Drug-Eluting Stents Historic Market Scenario in US$ Million by Coating: 2009-2017 |
| Brazilian Drug-Eluting Stents Market Share Analysis by Coating: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Quantitative Demand Analysis in Brazil in US$ Million by Application: 2018-2025 |
| Brazilian Drug-Eluting Stents Historic Market Review in US$ Million by Application: 2009-2017 |
| Brazilian Drug-Eluting Stents Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Drug-Eluting Stents Quantitative Demand Analysis in Brazil in US$ Million by End-Use: 2018-2025 |
| Brazilian Drug-Eluting Stents Historic Market Review in US$ Million by End-Use: 2009-2017 |
| Brazilian Drug-Eluting Stents Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| Mexico |
| Drug-Eluting Stents Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Coating for the Period 2018-2025 |
| Mexican Drug-Eluting Stents Historic Market Analysis in US$ Million by Coating: 2009-2017 |
| Mexican Drug-Eluting Stents Market Share Breakdown by Coating: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Mexican Drug-Eluting Stents Market in Retrospect in US$ Million by Application: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in Mexico by Application: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025 |
| Mexican Drug-Eluting Stents Market in Retrospect in US$ Million by End-Use: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in Mexico by End-Use: 2009 VS 2019 VS 2025 |
| Rest of Latin America |
| Rest of Latin America Drug-Eluting Stents Market Estimates and Projections in US$ Million by Coating: 2018 to 2025 |
| Drug-Eluting Stents Market in Rest of Latin America by Coating: A Historic Review in US$ Million for 2009-2017 |
| Rest of Latin America Drug-Eluting Stents Market Share Breakdown by Coating: 2009 VS 2019 VS 2025 |
| Rest of Latin America Drug-Eluting Stents Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Drug-Eluting Stents Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2009-2017 |
| Drug-Eluting Stents Market Share Breakdown in Rest of Latin America by Application: 2009 VS 2019 VS 2025 |
| Rest of Latin America Drug-Eluting Stents Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025 |
| Drug-Eluting Stents Historic Demand Patterns in Rest of Latin America by End-Use in US$ Million for 2009-2017 |
| Drug-Eluting Stents Market Share Breakdown in Rest of Latin America by End-Use: 2009 VS 2019 VS 2025 |
| Middle East |
| The Middle East Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Drug-Eluting Stents Market in the Middle East by Region/Country in US$ Million: 2009-2017 |
| The Middle East Drug-Eluting Stents Market Share Breakdown by Region/Country: 2009, 2019, and 2025 |
| The Middle East Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2018 to 2025 |
| The Middle East Drug-Eluting Stents Historic Market by Coating in US$ Million: 2009-2017 |
| Drug-Eluting Stents Market in the Middle East: Percentage Share Breakdown of Sales by Coating for 2009, 2019, and 2025 |
| The Middle East Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Drug-Eluting Stents Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| The Middle East Drug-Eluting Stents Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| The Middle East Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025 |
| Drug-Eluting Stents Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017 |
| The Middle East Drug-Eluting Stents Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| Iran |
| Iranian Market for Drug-Eluting Stents: Annual Sales Estimates and Projections in US$ Million by Coating for the Period 2018-2025 |
| Drug-Eluting Stents Market in Iran: Historic Sales Analysis in US$ Million by Coating for the Period 2009-2017 |
| Iranian Drug-Eluting Stents Market Share Analysis by Coating: 2009 VS 2019 VS 2025 |
| Iranian Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by Application: 2018 to 2025 |
| Iranian Drug-Eluting Stents Market in US$ Million by Application: 2009-2017 |
| Drug-Eluting Stents Market Share Shift in Iran by Application: 2009 VS 2019 VS 2025 |
| Iranian Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by End-Use: 2018 to 2025 |
| Iranian Drug-Eluting Stents Market in US$ Million by End-Use: 2009-2017 |
| Drug-Eluting Stents Market Share Shift in Iran by End-Use: 2009 VS 2019 VS 2025 |
| Israel |
| Israeli Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2018-2025 |
| Drug-Eluting Stents Market in Israel in US$ Million by Coating: A Historic Review for the Period 2009-2017 |
| Israeli Drug-Eluting Stents Market Share Breakdown by Coating: 2009 VS 2019 VS 2025 |
| Israeli Drug-Eluting Stents Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Drug-Eluting Stents Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Israeli Drug-Eluting Stents Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Israeli Drug-Eluting Stents Addressable Market Opportunity in US$ Million by End-Use: 2018-2025 |
| Drug-Eluting Stents Market in Israel: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017 |
| Israeli Drug-Eluting Stents Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| Saudi Arabia |
| Saudi Arabian Drug-Eluting Stents Market Growth Prospects in US$ Million by Coating for the Period 2018-2025 |
| Drug-Eluting Stents Historic Market Analysis in Saudi Arabia in US$ Million by Coating: 2009-2017 |
| Saudi Arabian Drug-Eluting Stents Market by Coating: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Saudi Arabian Demand for Drug-Eluting Stents in US$ Million by Application: 2018 to 2025 |
| Drug-Eluting Stents Market Review in Saudi Arabia in US$ Million by Application: 2009-2017 |
| Saudi Arabian Drug-Eluting Stents Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Saudi Arabian Demand for Drug-Eluting Stents in US$ Million by End-Use: 2018 to 2025 |
| Drug-Eluting Stents Market Review in Saudi Arabia in US$ Million by End-Use: 2009-2017 |
| Saudi Arabian Drug-Eluting Stents Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| United Arab Emirates |
| Drug-Eluting Stents Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Coating for the Period 2018-2025 |
| United Arab Emirates Drug-Eluting Stents Historic Market Analysis in US$ Million by Coating: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in United Arab Emirates by Coating: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025 |
| United Arab Emirates Drug-Eluting Stents Historic Market Analysis in US$ Million by Application: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in United Arab Emirates by Application: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2018-2025 |
| United Arab Emirates Drug-Eluting Stents Historic Market Analysis in US$ Million by End-Use: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in United Arab Emirates by End-Use: 2009 VS 2019 VS 2025 |
| Rest of Middle East |
| Drug-Eluting Stents Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Coating for the Period 2018-2025 |
| Rest of Middle East Drug-Eluting Stents Historic Market Analysis in US$ Million by Coating: 2009-2017 |
| Rest of Middle East Drug-Eluting Stents Market Share Breakdown by Coating: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Rest of Middle East Drug-Eluting Stents Market in Retrospect in US$ Million by Application: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in Rest of Middle East by Application: 2009 VS 2019 VS 2025 |
| Drug-Eluting Stents Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025 |
| Rest of Middle East Drug-Eluting Stents Market in Retrospect in US$ Million by End-Use: 2009-2017 |
| Drug-Eluting Stents Market Share Distribution in Rest of Middle East by End-Use: 2009 VS 2019 VS 2025 |
| Africa |
| African Drug-Eluting Stents Market Estimates and Projections in US$ Million by Coating: 2018 to 2025 |
| Drug-Eluting Stents Market in Africa by Coating: A Historic Review in US$ Million for 2009-2017 |
| African Drug-Eluting Stents Market Share Breakdown by Coating: 2009 VS 2019 VS 2025 |
| African Drug-Eluting Stents Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Drug-Eluting Stents Historic Demand Patterns in Africa by Application in US$ Million for 2009-2017 |
| Drug-Eluting Stents Market Share Breakdown in Africa by Application: 2009 VS 2019 VS 2025 |
| African Drug-Eluting Stents Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025 |
| Drug-Eluting Stents Historic Demand Patterns in Africa by End-Use in US$ Million for 2009-2017 |
| Drug-Eluting Stents Market Share Breakdown in Africa by End-Use: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 38 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com